FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
health.wusf.usf.edu1h
Antidepressants harder to quit than heroin? Fact-checking RFK Jr.
During his Senate confirmation hearing to serve as Health and Human Services Secretary, Robert F. Kennedy, Jr. suggested ...